Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Context Therapeutics Inc. Director's Dealing 2025

Jan 15, 2025

34269_dirs_2025-01-14_25c1d276-eabd-4454-94af-e9c76756f1d7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2025-01-13

Reporting Person: Pasternak Andy (Director)

More from Context Therapeutics Inc.

Regulatory Filings 2026
May 18
Annual Report 2026
Apr 28
Regulatory Filings 2026
Apr 2
Regulatory Filings 2026
Mar 23
Regulatory Filings 2026
Feb 27
Director's Dealing 2026
Feb 23
Director's Dealing 2026
Feb 23
Director's Dealing 2026
Feb 23
Director's Dealing 2026
Feb 23
Major Shareholding Notification 2026
Feb 17
View all filings →